Brief: Active Biotech Q4 Operating Loss Widens To SEK 11.2 Mln

Active Biotech AB publ

06/02/2020 07:46

Feb 6 (Reuters) - Active Biotech AB  ACTI.ST :
    * YEAR-END REPORT JANUARY - DECEMBER 2019
    * Q4 OPERATING LOSS SEK 11.2 MILLION VERSUS LOSS SEK 7.1
MILLION
YEAR AGO
    * Q4 NET SALES SEK 0.9 MILLION VERSUS SEK 4.8 MILLION YEAR
AGO

Source text for Eikon:  ID:nGNE9r9PKr 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))